FDA Approves Aducanumab — A Controversial Drug For Alzheimer's
The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical about whether the drug works. Rhitu Chatterjee talks with science correspondent Jon Hamilton about the controversial drug aducanumab and why the U.S. Food and Drug Administration approved it. For more of Jon's reporting, read "For…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Short Wave →
The Bumpy Road To Approving New Alzheimer’s Drugs
An Alzheimer's uproar
33%Alzheimer's drug breakthrough, and sugar in space
#71: Alzheimer’s treatment approved; human brain map breakthrough; time flowing backwards
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.